AU2001268737A1 - Methods to screen for antibiotic agents and their use in treatment of opportunistic infections - Google Patents
Methods to screen for antibiotic agents and their use in treatment of opportunistic infectionsInfo
- Publication number
- AU2001268737A1 AU2001268737A1 AU2001268737A AU6873701A AU2001268737A1 AU 2001268737 A1 AU2001268737 A1 AU 2001268737A1 AU 2001268737 A AU2001268737 A AU 2001268737A AU 6873701 A AU6873701 A AU 6873701A AU 2001268737 A1 AU2001268737 A1 AU 2001268737A1
- Authority
- AU
- Australia
- Prior art keywords
- screen
- treatment
- methods
- opportunistic infections
- antibiotic agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000001388 Opportunistic Infections Diseases 0.000 title 1
- 230000003115 biocidal effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21557200P | 2000-06-30 | 2000-06-30 | |
| US60215572 | 2000-06-30 | ||
| PCT/US2001/020520 WO2002001953A1 (en) | 2000-06-30 | 2001-06-28 | Methods to screen for antibiotic agents and their use in treatment of opportunistic infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001268737A1 true AU2001268737A1 (en) | 2002-01-14 |
Family
ID=22803502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001268737A Abandoned AU2001268737A1 (en) | 2000-06-30 | 2001-06-28 | Methods to screen for antibiotic agents and their use in treatment of opportunistic infections |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US6913889B2 (en) |
| AU (1) | AU2001268737A1 (en) |
| WO (1) | WO2002001953A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7790184B2 (en) * | 2006-08-01 | 2010-09-07 | Washington University In St. Louis | Cytochrome c synthesis inhibitors |
| KR20180105730A (en) | 2010-07-19 | 2018-09-28 | 아이오니스 파마수티컬즈, 인코포레이티드 | Modulation of dystrophia myotonica-protein kinase (dmpk) expression |
| US10000557B2 (en) * | 2012-12-19 | 2018-06-19 | Dnae Group Holdings Limited | Methods for raising antibodies |
| TW201536329A (en) | 2013-08-09 | 2015-10-01 | Isis Pharmaceuticals Inc | Compound and method for regulating the manifestation of dystrophic myotonic protein kinase (DMPK) |
| US11833221B2 (en) | 2021-09-01 | 2023-12-05 | Ionis Pharmaceuticals, Inc. | Oligomeric compounds for reducing DMPK expression |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4981692A (en) * | 1983-03-24 | 1991-01-01 | The Liposome Company, Inc. | Therapeutic treatment by intramammary infusion |
| US5871951A (en) * | 1996-09-23 | 1999-02-16 | The Children's Hospital Of Philadelphia | Compositions and methods for treatment of infection caused by Haemophilus influenzae and Streptococcus pneumoniae |
-
2001
- 2001-06-28 AU AU2001268737A patent/AU2001268737A1/en not_active Abandoned
- 2001-06-28 WO PCT/US2001/020520 patent/WO2002001953A1/en not_active Ceased
-
2002
- 2002-12-16 US US10/320,210 patent/US6913889B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6913889B2 (en) | 2005-07-05 |
| WO2002001953A1 (en) | 2002-01-10 |
| US20030203378A1 (en) | 2003-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001285020A1 (en) | P97-active agent conjugates and their methods of use | |
| AU2001288432A1 (en) | Materials and methods to potentiate cancer treatment | |
| AU2001272935A1 (en) | Cobalamin compounds useful as antibiotic agents and as imaging agents | |
| AU1525101A (en) | Absorbent bodies for applying to skin and mucusa surfaces | |
| AU1166502A (en) | Human ect2 and methods of use | |
| HUP0301815A3 (en) | Mono and disaccharide-based pharmaceutical composition for infections and other diseases and prophylactic and therapeutic treatment | |
| HUP0301121A3 (en) | Topical pharmaceutical formulations and methods of treatment | |
| AU5250901A (en) | Methods and devices for reducing trembling | |
| AU2002225954A1 (en) | Dipeptidylpeptidases and methods of use | |
| AU2002230836A1 (en) | Benzylamine derivatives and their use as thrombin inhibitors | |
| AU4340700A (en) | Methods and compositions for use in the treatment of hyperlipidemia | |
| GB2353612B (en) | Processing by use of synchronised tuple spaces and assertions | |
| AU2001281140A1 (en) | Anti-plasmodium compositions and methods of use | |
| AU2001283285A1 (en) | Antimicrobial composition and methods of use in the treatment of disease | |
| AU2003279526A1 (en) | Identifying and treating vaginal infections | |
| AU2002241661A1 (en) | Multifunctional protease inhibitors and their use in treatment of disease | |
| AU5114000A (en) | P43 anti-tumor therapeutic agent and three dimensional structure of its cytokinedomain | |
| AU2002239485A1 (en) | Methods for improved diagnosis and treatment of mycobacterial infections | |
| AU2001268737A1 (en) | Methods to screen for antibiotic agents and their use in treatment of opportunistic infections | |
| AU2002220257A1 (en) | Methods of treatment involving human mda-7 | |
| AUPN907296A0 (en) | Biocontrol agents for use in treatment of opportunistic infections | |
| AU2001261375A1 (en) | Human caspase-12 materials and methods | |
| AU3501700A (en) | Human endokine alpha and methods of use | |
| AU2002228660A1 (en) | Use of amidoamines to treat or prevent acanthamoeba and fungal infections | |
| AU2003267948A8 (en) | Aminoglycoside antibiotics and methods of using same |